Deerfield, IL, March 14, 2017 –Takeda Pharmaceuticals U.S.A., Inc. received an award from the Illinois Committee of the Employer Support of the Guard and Reserve (ESGR) during a recent ceremony at the Naval Station Great Lakes in Waukegan, Illinois to recognize the company for its support of employees involved in the National Guard and Reserve. In addition, Takeda employee Scott Maxson also received an individual award from ESGR based on the nomination of an employee reservist.
The recognition program is led by the ESGR, an organization under the U.S. Department of Defense. ESGR was established in 1972 to promote cooperation and understanding between employers and its civilian employees regarding an employee’s military commitment. Takeda earned the Pro Patria Award, the highest recognition given by the U.S. government to an employer ‘who demonstrates exceptional support for national defense by adopting personnel policies that make it easier’ for employees to participate in the National Guard and Reserve.
"We’re proud of the supportive environment we have established for our reservists and military veterans. This award recognizes our commitment to military-connected employees and their families, which are only one of the many employee groups supported by Takeda’s diverse programs and policies," said Laurene Giagnorio, senior vice president, human resources and administration, Takeda Pharmaceuticals U.S.A., Inc.
Takeda has received several consecutive workplace awards for its outstanding employee programs, Giagnorio explains. One of those programs includes sponsoring six employee resource groups (ERGs), which help build a more supportive and inclusive culture. The ERG for military-connected employees, called Supporting Troops and Inspiring Veteran Engagement (STRIVE), is among the company’s largest ERG with over 200 members.
Takeda’s Scott Maxson, manager of security and intelligence, also was recognized at the ceremony and received the Patriot Award for his continued support of a team member’s military service commitment, including a recent month-long assignment as part of his Navy Reservist status.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology, central nervous system and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
For more information, visit http://www.takeda.com/news
About Takeda in the U.S.
Takeda Pharmaceuticals U.S.A., Inc. is the U.S. commercial organization of Takeda Pharmaceutical Company Limited. Takeda has a strong commitment to the U.S. with more than 5,000 employees, a significant R&D presence, Oncology and Vaccine headquarters and manufacturing capabilities.